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Sirenomelia is a very rare limb anomaly in which the normally paired lower limbs are replaced by a single midline
limb. This study describes the prevalence, associated malformations, and maternal characteristics among cases
with sirenomelia. Data originated from 19 birth defect surveillance system members of the International
Clearinghouse for Birth Defects Surveillance and Research, and were reported according to a single pre-
established protocol. Cases were clinically evaluated locally and reviewed centrally. A total of 249 cases with
sirenomelia were identified among 25,290,172 births, for a prevalence of 0.98 per 100,000, with higher
prevalence in the Mexican registry. An increase of sirenomelia prevalence with maternal age less than 20 years
was statistically significant. The proportion of twinning was 9%, higher than the 1% expected. Sex was
ambiguous in 47% of cases, and no different from expectation in the rest. The proportion of cases born alive,
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premature, and weighting less than 2,500 g were 47%, 71.2%, and 88.2%, respectively. Half of the cases with
sirenomelia also presentedwith genital, large bowel, and urinary defects. About 10–15%of the cases had lower
spinal column defects, single or anomalous umbilical artery, upper limb, cardiac, and central nervous system
defects. Therewas a greater than expected association of sirenomeliawith other very rare defects such as bladder
exstrophy, cyclopia/holoprosencephaly, and acardia-acephalus. The application of the new biological network
analysis approach, including molecular results, to these associated very rare diseases is suggested for future
studies.  2011 Wiley Periodicals, Inc.
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INTRODUCTION
According to Stevenson [2006] ‘‘Sire-
nomelia is a limb anomaly in which the
normally paired lower limbs are replaced
by a single midline limb.’’ This
is probably the best definition in the
literature because it does not use the
term ‘‘fusion.’’ Other definitions char-
acterize sirenomelia as different degrees
of fusion between the lower limbs.
However, the term ‘‘fusion,’’ derived
from Latin fundere, should be avoided
because, as a noun derived from Latin
fundere, it implies the uniting of separated
parts, in this case the para-medial limb
buds, which is an unproven mechanism
of production for sirenomelia.
Definition and Diagnostic
Challenges
Even when sirenomelia seems to be a
discrete andwell-defined anomaly, some
difficulties can be encountered in its
delineation. On one hand, if its defi-
nition as the presence of an axial
positioned single lower limb is accepted,
the first three of the seven types in
Stocker and Heifetz [1987] classification
(see next section on Classification)
cannot be included as sirenomelias since
they do not present an axial single lower
limb. On the other hand, extended
crural or multiple crural-popliteal-talus
pterygia can overlap with Type-I sire-
nomelia from the clinical and radio-
logical standpoints. Furthermore, when
associated with other unrelated anoma-
lies such as craniofacial, sirenomelia
may overlap with multiple pterygium
syndromes of the Bartsocas–Papas
[Bartsocas and Papas, 1972], or Aslan
type [Aslan et al., 2000], OMIM 263650
and 605203, respectively. However,
popliteal pterygia associated with caudal
regression spectrum (CRS; caudal dys-
genesis) were described in a child born
from a diabetic mother [Al Kaissi et al.,
2008].
ICD-10 lacks a specific code for
sirenomelia, which must be coded as
Q87.2 ‘‘congenital malformation syn-
dromes predominantly affecting limbs.’’
This is a serious limitation for the
study of time-space clusters, as reported
from South America [Castilla et al.,
2008; Orioli et al., 2009], as well as for
statutory birth defects registries that only
use ICD-10 as the basis for their coding
system for congenital anomalies. The
pediatric extension of ICD10 (BPA) has
a specific code for ‘‘sirenomelia syn-
drome’’ which is Q87.24.
Prenatal diagnosis of sirenomelia by
ultrasound is impaired by the coexisting
oligohydramnion resulting from the
frequently associated bilateral renal a/
dysgenesis [Wasnik and Lalchandani,
2010]. However, there is a narrow
window, between weeks 8 and 16 of
gestation, that is, when the limb struc-
tures are visible to ultrasound, and the
amniotic fluid still depends mainly from
maternal production,whenvisualization
of sirenomelia is possible [Valenzano
et al., 1999; Schiesser et al., 2003].
Nevertheless, first trimester ultrasono-
graphic examinations are infrequent
and only a few cases of early diagnos-
ed sirenomelia have been reported
[Blaicher et al., 2001; Carbillon et al.,
2001; Akbayir et al., 2008]. Patel and
Suchet [2004] applied color and power
Doppler ultrasound to diagnose second
and third trimester fetuses with sireno-
melia mainly based on fetal vascular
images.
Classification
Sirenomelia was first classified into three
types according to the number of feet
and named sympus apus, monopus, and
dipus, for none, one, or two feet,
respectively [Foerster, 1861–1865]. A
more adequate classification of sireno-
melia is that of Stocker and Heifetz
[1987] in which seven types are defined:
I, all thigh and leg bones present;
II, single fibula; III, absent fibulae;
IV, partially fused femurs, fused
fibulae; V, partially fused femurs, absent
fibulae; VI, single femur, single tibia;
VII, single femur, absent tibiae. How-
ever, none of these classifications follow
ICD-10 lacks a specific code for
sirenomelia, which must be
coded as Q87.2 ‘‘congenital
malformation syndromes
predominantlyaffecting limbs.’’
This is a serious limitation
for the study of time-space
clusters, as reported from South
America, aswell as for statutory
birth defects registries that only
use ICD-10 as the basis for
their coding system for
congenital anomalies.
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a dysmorphogenetic rationale, propos-
ing nothing more than discrete group-
ings of a continuous spectrum.
Historical Aspects
Very rare congenital defects (VRDs),
having an expected occurrence rate of 1
per 100,000 or lower, were expected to
happen only once every several gener-
ations in most ancient populations at
the time of polytheist religions, when
several VRDs became mythological
figures. Early human populations were
mostly rural, and urban areas seldom
passed over 1,000 inhabitants, except for
classical Athens, one of the first known
city-state, with about 100,000 residents
in the late 5th and 4th century BC
[Scheidel, 2008]. Thus, even with a
natality rate as high as 50 per thousand
per year, no more than one case of a
given VRD every 20 years or more was
to be expected (i.e., approximately one
case per generation, assuming 25 years
per generation). Pictured or written
descriptions probably facilitated the
recording and/or historical recognition
of a given VRD. Nevertheless,
the large time-lapse between occur-
rences in ancient populations probably
allowed for magical or mythological
thinking about such defects [Stahl and
Tourame, 2010].
Sirenomelia, cyclopia, and, to a
lesser degree, conjoined twins received
special attention in most fantasies, my-
thologies, and religions, in which these
defects seem to have been taken more
as caprice of nature than as real mon-
strosities. Sirenomelia is referred as
‘‘mermaid’’ in mythology, that is: as a
female, more frequently than as the male
counterpart ‘‘merman,’’ or Triton type
sirenomelia, probably due to the more
attractive and esthetic sensual attributes,
as bosom, eyes, and hair in the female
gender when external genitalia was
omitted.
Embryology
Normal development: Morphology. In the
mouse, each lower limb derives from a
different para-medial developmental
field determined at gastrulation due to
the expression of Pitx1-dependent Tbx4
[Ouimette et al., 2010]. This process
occurs over 25 days, beginning at week 4
after fertilization, and by the end of
the eighth week, the limb is perfectly
formed. Lower limbs are delayed 2 days
in comparison to forelimbs. The trigger
for limb bud initiation is unknown, even
though fibroblast growth factors 8 and
10 are hypothesized as being involved
[Agarwal et al., 2003].
Limb development is a continuous
process that encompasses meso- and
ectodermal components and is divided
into four stages: the bud (outgrowth),
the paddle (dorso-ventral flattening),
the plate (relative expansion of the distal
end), and the rotation (around the
proximo-distal axis). In the latter stage,
the position of the limb buds relative to
the trunk change due to the differentiate
growth of the cartilage model that
continues to elongate the limb, with
different parts growing at different rates.
Lower limbs twist around their proxi-
mo-distal axis medially (internally)
bringing the great toe to the midline
from its initial postaxial position [Larsen,
1993].
Abnormal development: Dysmorphology.
Two main non-mutually exclusive hy-
potheses were advanced to explain the
abnormal development of the lower
limbs leading to sirenomelia: blastoge-
netic and vascular. The former hypoth-
esis postulates a primary anomaly in the
development of the caudal axial meso-
derm [Ka¨lle´n and Winberg, 1974;
Opitz et al., 2002; Kjaer et al., 2003;
Garrido-Allepuz et al., 2011], while the
latter is based on an abnormal develop-
ment of the umbilical vessels resulting in
a deficient blood supply of the caudal
part of the embryo [Kampmeier, 1927;
Hentschel et al., 2006]. This latter
hypothesis is supported by observations
of caudal ‘‘vascular steal’’ through a
persistent vitelline artery [Stevenson
et al., 1986; Bianchi et al., 2000; Patel
and Suchet, 2004]. There have been
several case reports supporting the
vascular hypothesis [Hentschel et al.,
2006; Duesterhoeft et al., 2007] as well
as some rejecting it [Jaiyesimi et al.,
1998]. Since these hypotheses are ex-
tended to the whole CRS, as well as to
other associated defects, it is feasible that
both hypotheses are valid, even allowing
for additional possible pathogenetic me-
chanisms to be proposed in the future.
Sirenomelia and caudal regression spectrum
(CRS). The concept of sirenomelia as
the most severe extreme of CRS was
advanced by Duhamel [1961], fitting
within the general concept of very rare
defects being extremes of dysmorpho-
logic spectra [Castilla and Mastroiacovo,
2011]. While sirenomelia and CRS
without sirenomelic share some com-
mon characteristics as male sex prefer-
ence, maternal diabetes, and absent
sacrum [Duesterhoeft et al., 2007],
associated defects as single umbilical
artery, lethal renal a/dysgenesis, and
oligohydramnios-related deformities
are much more frequent in the former
than in the latter [Ka¨lle´n and Winberg,
1974;Martı´nez-Frı´as et al., 2008]. Thus,
the concept of sirenomelia and caudal
dysgenesis being at the severest end of
the same CRS, proposed by Thottungal
et al. [2010] makes sense and incorpo-
rates most observations made until now
[Goodlow et al., 1988; Guidera et al.,
1991; Das et al., 2002].
Genetics and Clinical Genetics
As is the case with most, if not all
congenital anomalies, sirenomelia is
etiologically heterogeneous. No in-
stances of familial recurrence of sireno-
melia have been reported. However,
Sirenomelia was first classified
into three types according to the
number of feet and named
sympus apus, monopus, and
dipus, for none, one, or two feet,
respectively. A more adequate
classification of sirenomelia is
that of Stocker and Heifetz in
which seven types are defined.
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under the pathogenetic concept of
sirenomelia as part of the CRS, familial
cases are known. A pair of sirenomelic
concordant identical twins was reported
byDi Lorenzo et al. [1991]. Four siblings
with renal defects, one of them with
sirenomelia [Selig et al., 1993], are
considered to have renal adysplasia
(OMIM 191830), The renal adysplasia
patients can have mutations in the RET
gene (OMIM 164761) located at
10q11.2 or in the uroplakin IIIA gene
(UPK3A; OMIM 611559) located at
22q13.31. Sirenomelia was reported in
one case with an extra small bisatellit-
ed marker chromosome identified as
the proximal part of the long arm of
chromosome 22 [Jensen and Hansen,
1981]; probably this case was an earlier
example of UPK3A gene deletion.
Molecular studies in CRS show a
variety of specific anomalies: mutations
in the VANGL1 gene mapped at 1p13
for CRS [Kibar et al., 2007], a homeo-
box gene on chromosome 7q36 for
anorectal atresia [Lowry et al., 2007],
and mutations in HLXB9 gene for the
Currarino syndrome reported by Ko¨ch-
ling et al. [2001]. No gene mutations
have been reported in sirenomelia
patients.No SHHmutationswere found
by Vargas et al. [1998] in sacral agenesis/
sirenomelia cases. Sirenomelia can occur
in crosses between specific mice strains
and as consequence of mutations that
increase retinoic acid, as observed in
gene-knockouts of Cyp26 that codifies
for a retinoic acid degrading enzyme
(CYP26), recently revised by Pennim-
pede et al. [2010].
Zakin et al. [2005] have shown that
the lack of bone morphogenetic protein
7 (Bmp 7) in combination with half a
dose or complete loss of twisted gastru-
lation (Tsg) protein cause sirenomelia in
mice. Tsg is one of several regulators of
Bmp, whose gradient determines the
dorso-vertebral patterning in vertebrate
and invertebrate embryos. The same
team has earlier described that in the
absence of Tsg, the loss of one copy of
Bmp4 results in holoprosencephaly and
branchial arc defects [Zakin and De
Robertis, 2004]. Then, Tsg and Bmp
interaction seems doubly interesting to
the VRD studies, considering the oc-
currence of both conditions, sirenomelia
and holoprosencephaly, in the same
human newborn [Martı´nez-Frı´as et al.,
1998b].
A so-called ‘‘mermaid (merm)
mutant’’ (Nup133merm mutation) was
described disrupting mouse (mus muscu-
lus) gastrulation which is a functional
null allele of nucleoporin Nup133, a
constituent of the conserved Nup107-
160 complex [Garcı´a-Garcı´a et al.,
2005]. The phenotype in mice includes
exencephaly, shortened trunk, irregu-
larly segmented somites, and a minimal
tail bud.
Epidemiology: Prevalence,
Risk Factors
Prevalence. The birth prevalence of
sirenomelia varies from 1 to 2 per
100,000, depending on the denomina-
tor definition and case ascertainment
since one-third of the cases of sireno-
melia are stillborn [Ka¨lle´n et al., 1992;
Castilla and Orioli, 2004]. From 10% to
15% of occurrences are in twin births,
mostly monozygous [Valenzano et al.,
1999].
Due to the absence of external
genitalia and infrequent information on
gonadal or chromosomal sex, data on sex
distribution are very scarce. Nonethe-
less, the limited information available
indicates male sex preference [Duester-
hoeft et al., 2007], or does not indicate
any substantial sex preference [Ka¨lle´n
et al., 1992].
Clusters. A time-space cluster of sir-
enomelia in 2005 in the city of Cali
(Colombia) was reported by ECLAMC
(Spanish acronym for the Latin Ameri-
can Collaborative Study of Congenital
Malformations) [Castilla et al., 2008;
Orioli et al., 2009]. As with most
reported epidemics of congenital anom-
alies, except for phocomelia due to
maternal thalidomide exposure this
cluster ended spontaneously, without
identification of its cause. The most
interesting aspect of this cluster is the
nearly simultaneous rise and fall in the
birth prevalence rates of sirenomelia and
cyclopia, supporting the concept of
shared causal factors.
Maternal age. An international study
showed an U-shaped curve with in-
creased risk for sirenomelia at young
and old maternal ages: under 20, and
over 40 years old [Ka¨lle´n et al., 1992].
However this observation has not been
investigated further.
Maternal diabetes. One-fifth of pub-
lished sirenomelia cases were delivered
to diabetic mothers, the offspring of
whom are reported to have a prevalence
of one in 200 births for a sirenomelia/
caudal regression (CRS) infant
[Gurakan et al., 1996; Martı´nez-Frı´as
et al., 1998a; Al-Haggar et al., 2010].
However, in a 15-year pathology series
Bruce et al. [2009] found a history of
maternal diabetes in three out of nine
CRS cases, but in none of six cases of
sirenomelia.
Some associations with sirenomelia
and/or CRS such as VATER association
[Castori et al., 2010], pterygia [Al Kaissi
et al., 2008], and twinning [Zaw and
Stone, 2002] present with a history of
maternal diabetes providing clues for a
common risk factor. Castori et al. [2010]
report a diabetic mother having had
infants with sirenomelia and VATER
association from two out of her three
pregnancies, indicating a possible causal
relationship between maternal diabetes
and these two early blastogenic defects.
Beside this observation, these authors
also speculate on the pathogenetic
identity of both anomalies belonging to
the same dysmorphogenic spectrum.
These conclusions were based not
only on the reported case but also on
two previously published observations
[Valenzano et al., 1999; Castori et al.,
2008].
Environmental risk factors. Several
chemicals have been reported to induce
sirenomelia/CRS in experimental
mammals, including retinoic acid in
mice [Padmanabhan, 1998], cadmium
and lead in golden hamsters [Hilbelink
and Kaplan, 1986], and ochratoxin A in
chick embryos [Wei and Sulik, 1996].
Human reports on prenatal exposures
include cocaine [Sarpong and Headings,
1992], and an undefined ‘‘snuff ’’
[Taghavi et al., 2009]. A thorough
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review by Holmes [2002] found no
plausible teratogens associated with sir-
enomelia.
Associated and Combined
Anomalies
Since sirenomelia is not well delineated,
relative to the CRS, it is difficult to
specify which congenital anomalies are
pathogenetically associated with sireno-
melia. Association of sirenomelia/CRS
with component anomalies of the Potter
sequence is obviously expected due to
the an/oligohydramnios produced by
the usually associated severe and lethal
renal a/dysgenesis [Savader et al., 1989;
Al-Haggar et al., 2010]. An association
between sirenomelia/CRS and VATER
association could be explained by both
deriving from an early blastogenic insult,
when the potential embryo exists in a
single developmental field [Opitz et al.,
2002]. Epidemiological data supporting
this were provided by Duncan and
Shapiro [1993], Duncan et al. [1991],
and Schu¨ler and Salzano [1994]. Further
support came from clinical observations,
in which maternal diabetes provided an
etiological ground for both anomalies
[Kalter, 1993; Valenzano et al., 1999;
Castori et al., 2010], aswell as frommore
recent experimental studies with adria-
mycin in rats and mice [Abu-Hijleh
et al., 2000; Dawrant et al., 2007]. The
alternative approach of searching for
sirenomelia/CRS in association with
VATER in the same patient also pro-
vided support to this preferential associ-
ation [Botto et al., 1997; Rittler et al.,
1996].
Another potential similarity of
sirenomelia/CRS with VATER associ-
ation is imperforate anus, the A in
VATER acronym, which Duhamel
[1961] proposed as the mildest end of
the CRS. However, during the survey
of the epidemic of sirenomelia in the
city of Cali, variations in the birth
prevalence of imperforate anus was
analyzed as a sentinel phenotype for
minor forms of CRS, and no concomi-
tant rise in frequency was detected
[Castilla et al., 2008].
The reported association of sireno-
melia/CRS with neural tube defects
(NTD), mainly with spina bifida, is to
be expected since the lower spine is
affected in this anomaly [Ka¨lle´n et al.,
1992]. A more extended NTD in a
fetus with sirenomelia and acardia
was reported by Halder et al. [2001].
Sirenomelia and popliteal or multiple
pterygia were reported in some cases
[Aslan et al., 2000], and a common
causality due to maternal diabetes was
proposed [Al Kaissi et al., 2008].
Combined VRD. We are here naming
as ‘‘combined’’ VRD the concurrence
of two or more of the eight defects
(acardia, amelia, phocomelia, conjoined
twins, cyclopia, sirenomelia, bladder,
and cloaca esxtrophies) reported in this
series of articles with material from
ICBDSR [2009]. This is to distinguish
them from the commonly named ‘‘asso-
ciated’’ for the coexistence of sirenome-
lia with other unrelated congenital
anomalies. The occasional coincidence
of more than one VRD in the same
individual is difficult to accept as chance
occurrence, and a common etiopatho-
genic mechanism is more likely to
explain it since most of them are
presumably early blastogenic defects
[Opitz et al., 2002].
Sirenomelia–Cyclopia. There is evid-
ence for concurrence of sirenomelia
and cyclopia in the same patient
[Martı´nez-Frı´as et al., 1998b], being
associated with similar epidemiological
risk factors [Ka¨lle´n et al., 1992]; being
observed in the same clusters [Castilla
et al., 2008], and for potentially sharing
a similar pathogenetic mechanisms
[O’Railly and Mu¨ller, 1989].
Sirenomelia–Acardia. Concurrence in
the same case was documented by
Zanforlin Filho et al. [2007], as well as
by Halder et al. [2001].
Sirenomelia/CRS and situs inversus in
the same case were reported by Langer
et al. [1999] and Rougemont et al.
[2008].
Prognosis, Treatment, Survival,
and Prevention
Except for very rare instances, sireno-
melia is a lethal condition in the perinatal
period, hampering any intent of treat-
ment. In a large set of consecutive birth
series (10.1 million births), 97 cases of
sirenomelia were identified, 35 of them
in stillbirths, and 62 in live births who
died shortly after birth [Ka¨lle´n et al.,
1992].
In sirenomelia, the prognosis for
morbidity, survival, and quality of life
depends almost exclusively on the pres-
ence or not of congenital anomalies
affecting vital organs, such as renal
a/dysgenesis [Messineo et al., 2006].
There is documentation of one individ-
ual with sirenomelia born in the early
1990s that was claimed to be the second
surviving case of sirenomelia known
[Murphy et al., 1992], additionally, there
is documentation in 2003 of a 4-year-old
patient reported to be the fifth surviving
patient [Stanton et al., 2003].
Only about 1% of cases survive the
first week of life. Among these, three
cases with Stocker and Heifetz [1987]
types I to III of sirenomelia were widely
publicized through the lay press. One
of them was born in August 1999 in
Kennebunkport, Maine, USA, having a
small remnant of a kidney, 15 cm of large
intestine, one ovary, and absent uterus
and external genitalia. She underwent
two kidney transplants, dying at the age
of 10 years from pneumonia. The other
two cases still are still alive at present (in
2011), both of them, apparently having
no other major anomalies, and who un-
derwent successful surgery for leg sepa-
ration. However, as mentioned above,
these milder types could not be true
sirenomelias, but pterygia involving just
the soft tissues of lower limbs.
There is room for the primary
prevention of sirenomelia through the
appropriate pre-conceptional diagnosis
and treatment of all types of diabetes
that can lead to an exposure of the
early embryo to high levels of maternal
glycemia. In theory, asmany as 20%of all
cases of sirenomelia could be avoided
[Kadian et al., 2008; Delissaint and
McKyer, 2011].
In order to expand on the limited
epidemiologic information on sireno-
melia, we conducted a descriptive anal-
ysis of prevalence data collected on
sirenomelia by 19 program members
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of the International Clearinghouse for
Birth Defects Surveillance and Research
(hereafter referred to as ‘‘the Clearing-
house’’). In this analysis, we examined
the variation in prevalence by program,
over time, and by selected maternal and
infant characteristics.
METHODS
The Clearinghouse collects data from
46 member birth defect surveillance
programs around the world, sampling
out data from37 countries. Six countries
have two or more participating pro-
grams, and one (ECLAMC: Estudo
Colaborativo Latino Americano de
Malformac¸o˜es Congeˆnitas) including
hospitals from 10 different South
American countries. Each program
submits data in the same format to the
Clearinghouse for the annual report,
which includes detailed descriptions of
eachmember registry [ICBDSR, 2009].
Study Design and Cohorts
This was a retrospective cohort study
from population-based and hospital-
based birth defect surveillance programs.
Nineteen programs from North and
South America, Europe, China, and
Australia provided data on sirenomelia,
ascertained from a total birth population
of almost 25.3 million births. Birth years
included in the study ranged from 1968
to 2006, and varied by program. Births
included live births, stillbirths, and, for
some but not all programs, elective
pregnancy terminations for fetal anoma-
lies (ETOPFA).
Cases with sirenomelia were classi-
fied according to the number of defects
unrelated to the CRS [Orioli et al.,
2009]. Defects considered as related
to sirenomelia include urinary, genital,
large bowel, low spinal column, single
umbilical artery, and oligohydramnion
derived defects. Other types of defects
were grouped into 17 sets: other spinal
column or rib, small intestine, esophagus
or diaphragmatic, cardiac, upper limb,
abdominal or thoracic wall, ear, eye, oral
cleft, other facial, holoprosencephaly,
skin tag, situs inversus, hydrocephalus,
CNS, other artery, and other defects; and
each of them subdivided into different
sub-sets under different ad hoc codes.
The cases with sirenomelia were also
separated into isolated cases (i.e., cases
with no other defect outside the sireno-
melia spectrum reported in the same
case); and MCA (multiple congenital
anomalies) cases (i.e., cases with associ-
ated non-sirenomelia-spectrum defects
reported).
Programs were asked to provide
de-identified case records following a
common protocol, with information on
phenotype, genetic testing, and selected
demographic and prenatal information.
Further details can be found in Castilla
and Mastroiacovo [2011] in this issue.
Case Review
All records were reviewed by two
experienced dysmorphologists (PM,
IMO). When information was unclear
or missing, clarification and further data
were requested from the participating
program. All cases were reported verba-
tim and centrally classified.
Inclusions and Exclusions
Included were cases of sirenomelia, as
identified by the participating programs.
Cases with extended crural pterygium,
and non-medial single lower limb,
suggestive of lower limb amelia were
excluded. Spontaneous abortions (less
500 g, or 20 weeks gestation) were ex-
cluded among cases and denominators.
Statistical Methods
Occurrence was expressed as total prev-
alence (number of live births, stillbirths
and ETOPFA with sirenomelia per
100,000 births) with its 95% confidence
intervals (CI). For each program the
expected number of cases was calculated
under the hypothesis of a homogeneous
prevalence among all programs. Using
the expected values, we calculated the
exact Poisson probabilities of observing
N or more cases (P (NX)) in each
registry. Maternal age-specific preva-
lence ratios were calculated using the
number of total cases and all births (live
births and stillbirths) data by 5 years
maternal age groups and using the 25–
29 years group as the reference group.
Pearson correlation was used as a
measure of correlation between the
prevalence of sirenomelia and two
variables: the number of births and the
proportion of ETOPFA in each registry.
The 95% CI were computed using the
Poisson distribution. Statistical test sig-
nificance was set to P< 0.05. Statistical
analyses were done with Stata software,
version 10.0 [StataCorp, 2007].
RESULTS
Prevalence
The total number of births and of
sirenomelia cases is given in Table I for
each of the 19 surveillance programs
members of the International Clearing-
house for Birth Defects Surveillance and
Research (ICBDSR). A total of 249
cases with sirenomelia were identified
among 25,290,172 births, for a birth
prevalence of 1 per 100,758 births or
0.98 per 100,000 (95% CI 0.87–1.11).
The proportion of ETOPFA was
24.5% considering all reported cases.
ETOPFAwas not permitted in two sur-
veillanceprograms (MexicoRYVEMCE:
Registro y Vigilancia Epidemiolo´gica
de Malformaciones Conge´nitas; and
South America ECLAMC), and was
not recorded in another two (Spain
ECEMC: Spanish Collaborative Study
of Congenital Malformations; and
China, Beijing). Excluding these four
programs the proportion of ETOPFA
was 49.5%. There was no correlation
between the proportion of cases of
sirenomelia submitted to ETOPFA and
the sirenomelia prevalence (r¼ 0.25;
P¼ 0.37).
Figure 1 shows the sirenomelia
prevalence with their 95% CI in the dif-
ferent surveillance programs. Hungary
(0.33 per 100,000; 95% CI 0.16–0.61;
P< 0.0001) as well as Italy Campania
(0.16 per 100,000; 95% CI 0.00–0.87;
P< 0.013) show statistically significant
lower prevalence, suggesting under-
ascertainment. Five programs show a
statistically significant higher sirenome-
lia prevalence: Mexico RYVEMCE:
2.36 (95% CI 1.53–3.49; P< 0.0001),
South America ECLAMC: 1.36
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(95% CI 1.04–1.74; P< 0.006), Italy
North-East 1.69 (95% CI 1.03–2.60;
P< 0.009), Canada Alberta (1.6 per
100,000; 95% CI 0.93–2.56; P<
0.021), and Wales (2.25 per 100,000;
95% CI 0.73–5.25; P< 0.024). If we
discard the two registries with under-
ascertainment only the Mexican registry
had a higher prevalence than the other
registries.
There was no correlation between
the sirenomelia prevalence and number
of births in each surveillance program
(r¼ 0.03; P¼ 0.92). More than half
(53.4%) of the sirenomelia cases in this
study were provided by four reporting
surveillance programs: South America
ECLAMC, FranceCentral East,Mexico
RYVEMCE, and Italy North East.
Secular Variation
There is variation in the annual frequen-
cies of sirenomelia within each of the
19 programs. However, there were no
evident secular trends.
Maternal Age
For the maternal age analyses we
excluded sirenomelia cases and births
from China (before 1997 and after
2003), Italy North-East, and Italy Sicily
because the number of births by mater-
nal age was not available. Maternal age
was analyzed in six groups: less than
20 years, 20–24, 25–29, 30–34, 35–39,
and 40 years or older. In Table II the
sirenomelia prevalence for each mater-
nal age group and the prevalence ratios
for maternal age groups relative to the
reference age group of 25–29 years
with corresponding 95% CI are shown.
There was a clear gradient (Fig. 2) in
the sirenomelia prevalence from
younger to older maternal age groups
(P< 0.01), with the prevalence ratio
for maternal age less than 20 years
increased significantly (1.71; 95% CI
1.13–2.59). When the cases were sepa-
rated into isolated or MCA (multiple
congenital anomalies) groups (Table III),
the same prevalence trend and signifi-
cant prevalence ratio remained only for
the MCA group.
Sex
The sirenomelia spectrum of defects
includes external and internal genital
defects; thus making sex determination
difficult. Autopsy findings were more
helpful in the sex determination since
only 12 patients (8 females and 4 males)
had a karyotype result. In 11% of cases
the sex was unknown and 47.0% were
described as having ambiguous genitalia.
The proportion of males (49%) did not
differ from the 51% expected in the
sample of 105 patients with determined
sex. When grouping patients into iso-
lated and associated defects, the propor-
TABLE I. Total Prevalence (per 100,000 Births) of Sirenomelia in 19 Surveillance Programs Members of the International
Clearinghouse for Birth Defects Surveillance and Research
Surveillance program Period Births
Total
cases
% of
ETOPFA cases
Prevalence
(per 100,000 births)
95% Confidence
intervals (CI)
Canada Alberta 1980–2005 1,062,483 17 35.3 1.60 0.93–2.56
USA Utah 1997–2004 380,706 2 50.0 0.53 0.06–1.90
USA Atlanta 1968–2004 1,283,999 11 36.4 0.86 0.43–1.53
USA Texas 1996–2002 2,054,788 17 23.5 0.83 0.48–1.32
Mexico RYVEMCE 1978–2005 1,058,885 25 NP 2.36 1.53–3.49
South America ECLAMC 1982–2006 4,556,173 62 NP 1.36 1.04–1.74
Finland 1993–2004 713,494 5 60.0 0.70 0.23–1.64
Wales 1998–2004 222,309 5 80.0 2.25 0.73–5.25
Northern Netherlands 1981–2003 369,658 2 50.0 0.54 0.07–1.95
Slovak Republic 2000–2005 318,257 1 0 0.31 0.01–1.75
Hungary 1980–2005 3,022,194 10 10.0 0.33 0.16–0.61
France Central East 1979–2004 2,500,214 26 88.5 1.04 0.68–1.52
Italy North East 1981–2004 1,186,497 20 35.0 1.69 1.03–2.60
Italy Tuscany 1992–2004 336,744 4 50.0 1.19 0.32–3.04
Italy Campania 1992–2004 643,962 1 100 0.16 0.00–0.87
Italy Sicily 1991–2002 216,257 1 0 0.46 0.01–2.58
Spain ECEMC 1980–2004 2,045,751 13 NR 0.64 0.34–1.09
China Beijing 1992–2005 1,927,622 16 NR 0.83 0.47–1.35
Australia Victoria 1983–2004 1,390,179 11 36.4 0.79 0.39–1.42
25,290,172 249 24.5a 0.98 0.87–1.11
RYVEMCE,RegistroyVigilancia Epidemiolo´gica deMalformacionesConge´nitas; ECLAMC,EstudoColaborativo LatinoAmericano de
Malformac¸o˜es Congeˆnitas; ECEMC, Spanish Collaborative Study of Congenital Malformations; ETOPFA, elective termination of
pregnancy for fetal anomaly; NP, not permitted; NR, not reported.
aThe percentage computed on the 15 surveillance programs registering ETOPFA is 49.5% (n¼ 61/133).
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tion of unspecified sex was smaller in
the MCA (7.1%) than in the isolated
group (14.6%). The ETOPFA cases
had 47% of males among the small
sample of 43 patients with determined
sex; information on sex was missing
in only 3%, and not determined in 18%.
Other Risk Factors
Information on risk factors (i.e., mainly
maternal exposures during pregnancy)
was not available for most of the
registries. Among 133 informative cases,
there were seven (5%) with maternal
diabetes. Misoprostol first trimester
exposure was found in one case, and
fever in six cases (4.5%).
None of the 249 sirenomelia cases
had any indication of other family
members being affected by this or CRS.
Descriptive Analysis of
Sirenomelia Patients
There were 123 isolated cases (49%),
and 126 (51%) with other non-related
defects. In Table IVwe present the com-
parison of sex, outcome, birth weight,
gestational age, parity, previous sponta-
neous abortion, plurality, maternal age,
parental age difference, and maternal
education between isolated and MCA
sirenomelia cases. The associations with
maternal age and sex were already des-
cribed above. Pregnancy outcomes
among sirenomelia cases were: liveborn
47%, stillbirths 28.5%, and ETOPFA
24.5%. The proportion of ETOPFAwas
slightly higher in MCA cases (28.6%)
than in the isolated cases (20.3%), but
the difference did not reach statistical
significance (P¼ 0.13). For other preg-
nancy outcomes, the isolated and MCA
cases had similar distributions.
Only 11.1% of the sirenomelia
births weighed more than 2,500 g. The
proportion of cases who were low birth
weight did not differ between isolated
and MCA cases. Prematurity was found
in 71.2% of the cases, with 25.6% below
32 weeks, and 37.6% between 33 and
36 weeks of gestation, and no difference
between isolated and MCA cases. The
proportions of first births, previous
spontaneous abortion, years of parental
age difference and of maternal education
did not differ between the isolated
and MCA groups of sirenomelia cases,
and were similar to those expected in
the general population. However, the
proportion of multiple births among
sirenomelia cases was 8% versus an
expected rate of 1% or slightly more in
the general population.
Related and Unrelated Defects in
Sirenomelia
Singlemidline lower limb, reno-urinary,
genital, large bowel, low spinal column,
single or anomalous umbilical artery, and
oligohydramnios-derived defects were
in this work considered as part of the
sirenomelia sequence. Cases with sire-
nomelia that had other different defects
were classified as MCA cases. Cases with
inadequately described or minor defects
were not considered. The isolated group
(I) comprised of 123 infants (49%), and
the remaining 126 (51%)were divided in
groups having 1 (28%), 2 (16%), and 3 or
more unrelated defects (7%), The unre-
lated defects formed 17 groups of defects
coded ad hoc as explained in the
Methods Section. Since the description
Figure 1. Total prevalence per 100,000 births (bar) and 95% confidence interval
(line) by surveillance program and overall (dotted line) of sirenomelia in 19 surveillance
programsmembers of the International Clearinghouse for BirthDefects Surveillance and
Research (ICBDSR).
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of the specific defects is higher in
MCA groups with 812 specific defects
described in 126 patients (6.44 defects
by patient) than in the isolated group
with 346 specific defects in 123
patients (2.81 defects by patient), we
show the frequency of related defects
only in MCA group or in the total
sample.
Related Reno-Urinary Defects
Urinary defects were mentioned in
57.1% of MCA cases and in 46.6% of
all cases. Total absence of the reno-
urinary tree was described in 73.3% of
informative cases. Unilateral kidney
agenesis or bilateral hypoplasia was seen
in 9.5%, cystic or dysplastic kidneys in
12.9%, horseshoe kidney (including
horseshoe cystic kidney) in 5.2%, and
hydronephrosis in 4.3% of the cases.
Related Genital Defects
Genital defects were described in 59.5%
of MCA and in 57% of all patients.
Absence of total genitalia absence was
reported in 59.9%, and ambiguous
genitalia in 25.4% of all 142 informative
patients.
Related Lower Spinal Column
Defects
Most of the sirenomelia cases (80.2% in
MCA groups) had no lower spinal
column defects described, with this
defect being present in 16% of all
cases. Sacral or sacrococcygeal absence
was present in 59.9% of the 40 informa-
tive cases, and the sacral or sacrococcy-
geal defects described in 25.4% of these
cases.
Related Large Bowel Defects
Defects of the large intestine were
described in 62.7% of MCA cases, being
present in 53.4% of all cases. Anal atresia
was the most frequent defect, present in
91.0%of 133 informative cases. Anal and
intestinal duplication were described in
three cases.
Other Related Defects
Single or anomalous umbilical artery
was present in 16.5% and oligohydramn-
ion related defects in 24.9% of all cases.
Among the 62 cases with these defects,
12.4% were described as Potter anoma-
lies and 7.2% as lung hypoplasia.
Unrelated Defects
The 17 groups of unrelated defects
observed in the 126 MCA sirenomelia
patients were defined in the Methods
Section. Below they are summarized in
the limb, trunk, and head regions.
Limbs
The commonest non-related defects
(30.2%) among the MCA group were
those in the upper limb group. These
latter defects included: 14.3% of radial
TABLE II. Number of Births, Number of Cases Crude Prevalence Estimates, and Prevalence Ratios for Maternal Age
Groups Relative to the Reference Age Group of 25–29 Years for Sirenomelia
Maternal age group Birthsa Casesa
Prevalence
(per 100.000 births) 95% CI
Prevalence
ratio 95% CI
<20 2,334,023 35 1.50 1.04–2.09 1.71 1.13–2.59
20–24 5,922,300 56 0.95 0.71–1.23 1.08 0.75–1.55
25–29 7,079,853 62 0.88 0.67–1.12 1.00 (Reference)
30–34 4,966,752 43 0.87 0.63–1.17 0.99 0.67–1.46
35–39 2,024,166 12 0.59 0.31–1.04 0.68 0.36–1.26
40 or older 426,799 2 0.47 0.06–1.69 0.54 0.13–2.19
aCases and births excluded: China before 1997 and after 2003, ItalyNorth East, Italy Sicily because no births bymaternal agewere available.
Figure 2. Prevalence ratios for maternal age groups relative to the reference age
group of 25–29 years with corresponding 95% confidence intervals for sirenomelia in 19
surveillance program members of the International Clearinghouse for Birth Defects
Surveillance and Research (ICBDSR).
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aplasia/hypoplasia, 7.9% described as
upper limb reduction, and 3.2% as poly-
dactyly or pre-axial polydactyly; lobster
claw hands were described in three
(2.4%) sirenomelia cases; postaxial limb
reduction, webbed upper limbs and
upper limb joint contractures, with one
case each.
Trunk
Other or unspecified defects of spinal
column and of ribs were described in
21.4% of MCA cases of sirenomelia.
Cardiac defects were present in 20.6% of
MCA cases, with 4.8% presenting as
tetralogy of Fallot, 3.2% as single ven-
tricle, and 2.4% as left heart hypoplasia.
Defects of central nervous system were
described in 19.0% of MCA cases, with
spina bifida (mainly lower spina bifida)
reported in 10.3%, and microcephaly in
2.4% of the cases. Esophageal atresia/
fistula was described in 12.7% of MCA
cases, defects of the diaphragm in 3.2%
of such cases. In decreasing prevalence
order, the following defects were also
described: omphaloceles (5.6%) and
other abdominal wall defects (4.0%).
Other cases were reported as having
abdominal wall defect and ectopia
cordis, bladder exstrophy, bladder exs-
trophy with cephalic celosomia, and
gastroschisis (one case for each of these
associations).
Head
Hydrocephalus was present in 8.7% of
MCA cases. Microtia was described in
6.3% of MCA cases, and oral clefts in
5.1% of MCA cases. Eye defects were
reported in 5.6% of MCA cases, with
4.0% being microphthalmia. Several
cases (11.9%) had other facial defects,
including ocular hypertelorism seen in
3.2% of the MCA cases.
Other
Arterial defects different from single or
anomalous umbilical artery were des-
cribed in 9.5% ofMCA cases, with 4.0%
being persistent superior vena cava.
Duodenal atresia (4.8%), skin tag
(2.4%), and holoprosencephaly (one
case), were also described among the
unrelated defects. Since hydrocephalus
was frequent and could sometimes be
considered as a heterotaxic defect, it is
important to note that 5.6% of MCA
patients presented with other hetero-
taxic defects such as dextrocardia, spleen
agenesis or defect, and lung lobation
anomalies.
Syndromes or Associations
Chromosomal syndromes are not com-
mon among the sirenomelia cases. Only
12 cases of sirenomelia had karyotype
results and all such results were normal.
Monogenic syndromes were not
described in any cases. Considering the
association with other VRD there were
three cases combining sirenomelia and
bladder exstrophy, one from Mexico
registry and two, a twin pair, from
South America. Acardia-acephalus were
described in two cases with sirenomelia,
one from Spain [Martı´nez-Frı´as, 2009]
and one from South America. This last
case presented also with cyclopia and
was a casewith acardia-acephalus, cyclo-
pia, and sirenomelia. Also from South
America there were one case with
sirenomelia and conjoined twin and
other probable case of sirenomelia–
cyclopia, described as sirenomelia,
medial cleft lip, and ocular hypotelorism.
Another case from France presented
with sirenomelia and holoprosence-
phaly.
TABLE III. Number of Births, Number of Cases, Crude Prevalence Estimates, and Prevalence Ratios for Maternal Age
Groups Relative to the Reference Age Group of 25–29 Years for Isolated and MCA Sirenomelia
Maternal age group Birthsa Casesa
Prevalence
(per 100,000 births) 95% CI
Prevalence
ratio 95% CI
Isolated
<20 2,334,023 15 0.64 0.36–1.06 1.26 0.69–2.31
20–24 5,922,300 24 0.41 0.26–0.60 0.80 0.48–1.34
25–29 7,079,853 36 0.51 0.36–0.70 1.00 (Reference)
30–34 4,966,752 24 0.48 0.31–0.72 0.95 0.57–1.59
35–39 2,024,166 5 0.25 0.08–0.58 0.49 0.19–1.24
40 or older 426,799 2 0.47 0.06–1.69 0.92 0.22–3.83
MCA
<20 2,334,023 20 0.86 0.52–1.32 2.33 1.30–4.18
20–24 5,922,300 32 0.54 0.37–0.76 1.47 0.88–2.47
25–29 7,079,853 26 0.37 0.24–0.54 1.00 (Reference)
30–34 4,966,752 19 0.38 0.23–0.60 1.04 0.58–1.88
35–39 2,024,166 7 0.35 0.14–0.71 0.94 0.41–2.17
40 or older 426,799 0 0.00 0.00–0.86 0.00 NC
MCA, multiple congenital anomalies; NC, not computable.
aCases and births excluded: China before 1997 and after 2003, Italy North East, Italy Sicily because no births bymaternal agewere available.
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TABLE IV. Characteristics of the Infants With Sirenomelia
Total cases (n¼ 249) Isolated cases (n¼ 123)
Cases with associated
malformations (n¼ 126)
n % n % n %
Sex
Male 51 20.5 22 17.9 29 23.0
Female 54 21.7 22 17.9 32 25.4
Indeterminate 117 47.0 61 49.6 56 44.4
Missing data 27 10.8 18 14.6 9 7.1
Outcome
Livebirths 117 47.0 60 48.8 57 45.2
Stillbirths 71 28.5 38 30.9 33 26.2
ETOPFA 61 24.5 25 20.3 36 28.6
Missing data 0 0.0 0 0.0 0 0.0
Birth weight (g)a
<1,500 46 39.3 21 35.0 25 43.9
1,500–2,500 51 43.6 31 51.7 20 35.1
>2,500 13 11.1 5 8.3 8 14.0
Missing data 7 6.0 3 5.0 4 7.0
Gestational age (week)a
<32 30 25.6 14 23.3 16 28.1
33–36 44 37.6 22 36.7 22 38.6
37 30 25.6 18 30.0 12 21.1
Missing data 13 11.1 6 10.0 7 12.3
Parity
0 39 15.7 16 13.0 23 18.3
1 87 34.9 49 39.8 38 30.2
2 or more 35 14.1 17 13.8 18 14.3
Missing data 88 35.3 41 33.3 47 37.3
Previous spontaneous abortions
0 74 29.7 40 32.5 34 27.0
1 16 6.4 7 5.7 9 7.1
Missing data 159 63.9 76 61.8 83 65.9
Plurality
Single 204 81.9 101 82.1 103 81.7
Twin 20 8.0 11 8.9 9 7.1
Triplet 1 0.4 0 0.0 1 0.8
Missing data 24 9.6 11 8.9 13 10.3
Maternal age
<20 35 14.1 15 12.2 20 15.9
20–24 62 24.9 27 22.0 35 27.8
25–29 64 25.7 37 30.1 27 21.4
30–34 44 17.7 25 20.3 19 15.1
35 14 5.6 7 5.7 7 5.6
Missing data 30 12.0 12 9.8 18 14.3
Parental age difference
Mother same age or older 25 10.0 12 9.8 13 10.3
Mother 1–2 years younger 20 8.0 8 6.5 12 9.5
Mother 3–4 years younger 13 5.2 8 6.5 5 4.0
Mother >4 years younger 19 7.6 11 8.9 8 6.3
Missing data 172 69.1 84 68.3 88 69.8
Maternal education (years)
<9 21 8.4 15 12.2 6 4.8
9 or more 37 14.9 17 13.8 20 15.9
Missing data 191 76.7 91 74.0 100 79.4
aBirth weight, gestational age: the data are for livebirths only.
DISCUSSION
Prevalence
The sirenomelia prevalence observed in
this population of more than 25 million
births of 0.98 per 100,000 births did not
differ from previous estimates [Ka¨lle´n
et al., 1992; Castilla and Orioli, 2004].
The lower prevalence observed in the
Hungary registry could reflect some
under-ascertainment since only 10% of
the identified sirenomelias came from
ETOPFA, a proportion lower than the
percentage estimated from the 15 sur-
veillance programs registering ETOPFA
(49.5%). We observed statistically sig-
nificant higher sirenomelia prevalence in
the Mexican, South American, Italy
North-East, and Canada Alberta regis-
tries, and also a lower than expected
prevalence in the Italy Campania regis-
try. However, if we exclude the data
from Hungary and Italy Campania,
only the Mexican registry had a higher
sirenomelia prevalence than the other
registries.
The higher prevalence observed in
the Mexican registry has no direct
explanation. Other registries with limit-
ed or no recording of ETOPFA (e.g.,
South America, Spain, and China) did
not have a high prevalence of sirenome-
lia, so lack of ETOPFA does not seem to
be a likely explanation. The Mexican
population could be ethnically different
from the other studied populations,
having a higher proportion of Amer-
indians [Collins-Schramm et al., 2004];
however, it is unclear whether this
characteristic is likely to account for
the higher prevalence of sirenomelia.
Only specific case–control studies can
test this suggestion of an association
of sirenomelia with ethnicity. A more
specific hypothesis is that pre-gestational
diabetes (e.g., diagnosed and undiag-
nosed type 2 diabetes), which may be
more prevalent in the population cov-
ered by the Mexican registry than the
populations of other registries since the
prevalence of pre-gestational diabetes is
reported to be higher among pregnant
Hispanic women than among pregnant
non-Hispanic white women [Lawrence
et al., 2008]. However, we did not
have adequate data on pre-gestational
diabetes in our data to examine the
possible association of maternal pre-
gestational diabetes and sirenomelia.
There is a reasonable level of
confidence in the certainty of the
sirenomelia diagnosis in the 249 studied
cases. However, unilateral lower limb
amelia can sometimes be confounded
with sirenomelia when the only lower
limb has a median position. Since 40
cases (16%) were described only by the
word sirenomelia, it is possible that
diagnostic misclassification occurred in
a few instances.
Maternal Age
The higher prevalence of sirenomelia
observed in the younger maternal age
group (less than 20) is a new finding
in the epidemiology of sirenomelia.
Since twinning and maternal diabetes
are usually associated with sirenomelia,
and both conditions are more likely
to occur with older maternal age, the
higher prevalence of sirenomelia we
found in younger mothers was unex-
pected. Ka¨lle´n et al. [1992] suggested an
increased risk of sirenomelia in offspring
of young and older mothers, but such
findings were not statistically significant.
The higher sirenomelia prevalence we
observed in younger mothers was evi-
dent in the MCA case group but not in
the isolated case group. Since there was a
similar prevalence gradient in the total
data set, this lack of significance for the
isolated case group could reflect low
power of small sample sizes or, alter-
natively, indicate some etiologic differ-
ence between the isolated and the MCA
case groups (e.g., difference in pre-
gestational diabetes).
Sex
The sex in sirenomelia was generally
based on gonadal or, rarely, on chromo-
somal examination, which explains why
almost half of the cases had undeter-
mined sex. However, the cases with
determined sex did not show a higher
prevalence of males as suggested pre-
viously [Duesterhoeft et al., 2007]. In a
small sample of sirenomelia cases
(n¼ 32) studied by Ka¨lle´n et al. [1992],
there were more females than males.
However, this differencewas not statisti-
cally different from the expected male-
to-female sex ratio.
Other Risk Factors
Due to a lack of systematically collected
data on maternal conditions, we were
unable to confirm previous reports that
one-fifth of mothers of sirenomelic
infants have diabetes [Gurakan et al.,
1996; Martı´nez-Frı´as et al., 1998a; Al-
Haggar et al., 2010]. Our results, how-
ever, were more consistent with those of
other authors [Stocker and Heifetz,
1987; Duncan and Shapiro, 1993; Lynch
and Wright, 1997; Duesterhoeft et al.,
2007] that reported a lower prevalence
of maternal diabetes (i.e., less than 4%)
among cases of sirenomelia. The 5% of
diabetic mothers in our sample of 133
informative cases coincide with the
suggestion that diabetes could be a main
The higher prevalence of
sirenomelia observed in
the younger maternal
age group (less than 20) is
a new finding in
the epidemiology
of sirenomelia.
Due to a lack of systematically
collected data on maternal
conditions, we were unable
to confirm previous reports
that one fifth of mothers of
sirenomelic infants have
diabetes. Our results, however,
were more consistent with those
of other authors that reported a
lower prevalence of maternal
diabetes (i.e., less than 4%)
among cases of sirenomelia.
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factor in CRS but not in sirenomelia
[Bruce et al., 2009]. This does not
exclude the possibility that a few cases
of sirenomelia may have a pathogenesis
linked tomaternal diabetes that is similar
or identical to that of some CRS cases.
Descriptive Analysis
The infants with sirenomelia were born
alive in almost half of the cases which did
not undergo ETOPFA, and presented a
higher proportion of prematurity and of
twinning than expected. These charac-
teristics were the same in both the
isolated and MCA case groups.
Associated Defects
The division of infants with sirenomelia
into isolated and MCA case groups did
not show any epidemiological difference
between these two groups other than an
associationwithyounger maternal age in
theMCAgroup. The proportion of each
defect considered part of the sirenome-
lia/CRS spectrum was always higher,
although not statistically significantly, in
the MCA than in the isolated group,
suggesting that in the former group the
cases were described in more detail.
Since only 16% of patients had the
limited descriptor of ‘‘sirenomelia,’’ the
studied sample of 84% of cases seems
appropriate for evaluating the extension
of the sirenomelia/CRS spectrum.
Single umbilical artery, lethal
renal a/dysgenesis, and oligohydram-
nios, were described much more fre-
quently in sirenomelia than in CRS
non-sirenomelic [Ka¨lle´n and Winberg,
1974; Martı´nez-Frı´as et al., 2008].
Nonetheless, only the urinary defects,
as well as the genital, and large bowel
defects, were described in approximately
half of the cases with sirenomelia in our
sample. Single or anomalous umbilical
artery, as well as defects of the lower
spinal column, were described in only
16% of the cases, while oligohydramn-
ion derived defects in 24.9% of the case.
The differences in diagnostic methods
(clinical examination with or without
imaging studies or autopsy) does not
explain the observed differences of fre-
quency. However, we could not discard
that some defects of this spectrum with
wide phenotypic variability were pref-
erentially described in some registries.
Other defects were described in
sirenomelia with a frequency similar to
that of the lower spinal column defects
or single or anomalous umbilical artery
frequency. Upper limb defects, mainly
pre-axial reduction, congenital heart
defect, and central nervous system,
mainly spina bifida, occurred in 14.9%,
10.8%, and 10.4% of all cases, respec-
tively, and could be also accepted as
part of the sirenomelia/CRS spectrum.
Since only cases of sirenomelia were
studied here, we cannot assess the
prevalence of the abovementioned
defects in non-sirenomelic CRS case-
series. Therefore, for future work, the
observations here reported could only
suggest which defects to be included in
the sirenomelia spectrum, and which
considered as associated defects, that is,
not as part of the spectrum.
Several other early defects, such as
VATER and twinning, have been linked
to sirenomelia/CRS through common
risk factors such as maternal diabetes
[Zaw and Stone, 2002; Castori et al.,
2010] or through the overlapping of
the specific defects in each condition
[Ka¨lle´n and Winberg, 1974]. From the
five defects included in the VATER
acronym (Vertebral, Anal atresia,
Tracheo-Esophageal, Renal and Radial
anomalies), three (VAR) are already part
of the accepted sirenomelia/CRS spec-
trum. Even if we described among our
sirenomelia cases 28 with radial defects
and 16 with tracheo-esophageal anoma-
lies, only 3 cases presented exclusively
defects of the VATER association. Thus
the proposition of a unique spectrum for
sirenomelia/CRS and VATER [Castori
et al., 2010] was not supported by our
findings.
Some authors [Heifetz, 1984; Ste-
venson et al., 1986] which support the
vascular ‘‘steal’’ theory for sirenomelia
etiology have proposed that single um-
bilical artery or anomalous umbilical
artery were always present in sirenome-
lia. However, we could not confirm this
hypothesis with our findings. Because
single umbilical artery is considered
a minor defect and not reported by
some registries, the frequency we found
could very well represent an underesti-
mate. Garrido-Allepuz et al. [2011] have
updated the discussion about the two
hypotheses about sirenomelia etiology,
and pointed that both theories were not
mutually exclusive although the defi-
cient blastogenesis hypothesis explains
both the vascular and the organs defects.
The frequency of the associations of
VRD as those described here, involving
sirenomelia with bladder exstrophy,
holoprosencephaly/cyclopia, or acar-
dia-acephalus in the same infant is
greater than expected considering
the prevalence of each one of these
defects. Also the association in the same
infant of three VRD as sirenomelia,
acardia-acephalus, and cyclopia is never
expected to occur under random expec-
tations. These associations, the high
frequency of twinning, and the overlap
of defects with other early conditions as
VATER and CRS indicate a common
pathway for them. They could be the
result of early insults in blastogenesis
caused by the primary gene mutation or
by environmental determinants or by
interaction of both, and the final pheno-
type will depend on the disease modify-
ing genes, divided in those uniquely
affected by the primary mutation, and
those whose actions reflect generic
responses to organism stress evoked by
the principal mutation (intermediate
phenotypes). Since each path involves
concatenated networks, the application
of biological network analysis [Loscalzo
et al., 2007], together with molecular
results, could help us to understand this
class of complex diseases.
CONCLUSIONS
Sirenomelia prevalence was noted to
be higher in the Mexican registry (2.36
per 100,000) than in others registries,
with no plausible explanation identified
based on the available data. Prevalence
estimates of sirenomelia around the
world were similar otherwise (0.98 per
100,000), with exception of Hungary
and Campania-Italy registries where a
low prevalence suggests that under-
ascertainment could be occurring. The
proportion of twinning among cases of
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sirenomelia was higher than the 1 or 2%
expected in the general population. The
sirenomelia prevalence was also higher
in younger age mothers among all cases
and thosewithMCA, but not among the
isolated case. Half of the cases with
sirenomelia presented also with genital,
large bowel, and urinary defects. About
10–15% of sirenomelia cases had lower
spinal column defects, single or anom-
alous umbilical artery, upper limb,
cardiac, and central nervous system
defects. There was a higher than
expected association of sirenomelia with
other VRD such as bladder exstrophy,
cyclopia/holoprosencephaly, and acar-
dia-acephalus. The biological network
analysis approach of these related com-
plex conditions was suggested for future
work.
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